Skip to main content
Year archive

SUPHA PHARMACHEM LIMITED — 2025 filings

All 92 regulatory filings released by SUPHA PHARMACHEM LIMITED (539561) in 2025, sourced directly from the official regulator.

92 Filings
2025 Period
2025 filings (92)
Filing Released Lang
Intimation of closure of Trading Window
Regulatory Filings
2025-12-22 English
Company is pleased to informed that MCA has approved the change of name vide certificate of incorporation W.E.F. 15/12/2025 from REMEDIUM LIFECARE LTD. TO SUPHA PHARMACHEM LIMITED
Regulatory Filings
2025-12-15 English
Submission of postal ballot results and scrutinizer report
Declaration of Voting Results & Voting Rights Announcements
2025-12-08 English
Submission of outcome of postal ballot
Declaration of Voting Results & Voting Rights Announcements
2025-12-08 English
Newspaper Publication for unaudited financial results 30.09.2025
Report Publication Announcement
2025-11-17 English
Remedium Lifecare Delivers Strong Q2 Results with Profit Nearly Doubling to Rs.862.34 Lakh
Earnings Release Q2 2026
2025-11-17 English
Financial Results for Quarter and Half Year ended September 30, 2025
Interim / Quarterly Report H1 2026
2025-11-14 English
Board Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter and Half year Ended September 30, 2025
Interim / Quarterly Report H1 2025
2025-11-14 English
Remedium Lifecare Strengthens Leadership for Next-Phase Growth
Board/Management Information
2025-11-10 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Standalone and ....
Report Publication Announcement
2025-11-06 English
Newspapers publication for dispatch of postal ballot notice
Report Publication Announcement
2025-11-06 English
Submission of postal ballot notice
Proxy Solicitation & Information Statement
2025-11-04 English
Appointment
Board/Management Information
2025-10-31 English
the Board in ite metting approved 1. Appointed Mr. Rambhajan Vishwakarma . 2. Appointed Mr. Vignesh Laxman Gawde . 3. Approved the Postal Ballot notices 4. The Board has reconstituted ....
Regulatory Filings
2025-10-31 English
Resignation of Mr. Mansoor Abdul Vahab
Board/Management Information
2025-10-29 English
Compliance certificate under Reg. 74(5) of SEBI (DP) 30.09.2025
Regulatory Filings
2025-10-10 English
Resignation of Mr. Dipesh Vaidya Non- Executive Independent Director
Board/Management Information
2025-10-06 English
e-voting results of AGM and scrutinizer Report of AGM held on 24.09.2025 through VC/OAVM
Declaration of Voting Results & Voting Rights Announcements
2025-09-24 English
Proceedings of 36th AGM held on 24.09.2025 through VC/OAVM
Declaration of Voting Results & Voting Rights Announcements
2025-09-24 English
Intimation of closure of trading window
Regulatory Filings
2025-09-23 English
We wish to inform you that, the Board of Directors of the Company, at its meeting held today 22nd September, 2025 has inter- alia considered, approved and taken on record 1. Change of ....
Regulatory Filings
2025-09-22 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/09/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings
2025-09-16 English
Newspaper ad for AGM notice Dispatch
Report Publication Announcement
2025-09-06 English
submision of Annual Report 2024-25
Annual Report FY 2025
2025-09-03 English
36th Annual General Meeting of the company to be held on Wednesday, 24th September, 2025 at 11.00 a.m. through VC/OAVM
Proxy Solicitation & Information Statement
2025-09-03 English
Submission of newspaper publication intimating members for holding ensuing AGM for 2024-25 through VC/OAVM
Report Publication Announcement
2025-08-26 English
Remedium Lifecare Charts 4X Growth Path with Strategic Focus on 4-Point Strategy
Regulatory Filings Q1 2026
2025-08-25 English
Submission of Scrutinizer Report for postal Ballot process
Declaration of Voting Results & Voting Rights Announcements
2025-08-13 English
Outcome of Postal ballot - Proceedings
Declaration of Voting Results & Voting Rights Announcements
2025-08-13 English
Remedium Lifecare Kicks Off FY26 with ?464.88 Lakh PAT in Q1, Surpassing and Doubling FY25 Profit and Driving Expansion Plans
Earnings Release Q1 2026
2025-08-11 English
Results For The Quarter Ended June 30, 2025.
Interim / Quarterly Report Q1 2026
2025-08-04 English
Board Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2025
Interim / Quarterly Report Q1 2026
2025-08-04 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve the Unaudited Financial Results ....
Report Publication Announcement
2025-07-30 English
Remedium Lifecare Limited Charts Long-Term Growth with Global Subsidiary, Export Contract and Strong Investor Support
Report Publication Announcement
2025-07-21 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025
Regulatory Filings
2025-07-14 English
Newspaper Notice for postal Ballot
Report Publication Announcement
2025-07-11 English
Submission of Postal ballot notice and intimation of dispatch of postal ballot notice
Proxy Solicitation & Information Statement
2025-07-10 English
Intimation of Trading Window
Regulatory Filings
2025-06-24 English
Submission of Newspaper Clippings regarding Audited Financial Results for the quarter and Year ended 31.03.2025 published on 01.06.2025.
Regulatory Filings
2025-06-04 English
Intimation of Newspaper publication as per Regulation 92 of the SEBI(ICDR) Regulations, 2018 and Regulation 30 read with Schedule lll of SEBI(LODR) Regulations, 2015
Report Publication Announcement
2025-05-31 English
Appointment of Independet Director
Earnings Release FY 2025
2025-05-30 English
Appointment of Company Secretary and Compliance Officer
Earnings Release FY 2025
2025-05-30 English
The Audited Financial Results (Standalone and consolidated) of the Company for the last quarter and year ended March 31, 2025 and Audited Annual Accounts of the Company the quarter and ....
Earnings Release
2025-05-30 English
The Audited Finanacial Results (Standalone and Consolidated ) of the Company for Last Quarter and Year Ended March 31, 2025 and Audited Annual Accounts of the Company for the quarter and ....
Earnings Release FY 2025
2025-05-30 English
Compliances -Reg. 24A Annual Secretarial Compliance
Audit Report / Information FY 2025
2025-05-30 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the Audited Financial Results ....
Report Publication Announcement
2025-05-27 English
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Share Issue/Capital Change
2025-05-22 English
Remedium Lifecare Enhances R&D and CDMO, Secures ?182.7 Crore Export Deal
Regulatory Filings
2025-05-13 English
Remlife Global PTE LTD. A Wholly Own Subsidiary of Remedium Lifecare Limited Announces Strategic Partnership with JiyaYu Lifesciences to Replace Animal-Origin Inputs in APIs and Intermediates ....
Regulatory Filings
2025-05-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement
2025-05-05 English
Press Release - Ride the Pharma Wave with our Rights Issue
Report Publication Announcement
2025-05-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement
2025-04-29 English
Filing of Pre-Issue Advertisement pursuant to the proposed Rights Issue of Equity Shares of Remedium Lifecare Limited
Report Publication Announcement
2025-04-29 English
Pursuant to Regulation 30 of Securities and Exchange Board of India (LODR) Regulation 2015 , we hereby inform that Mr. Neeraj Yadav (Membership No. A73527), Company Secretary and Compliance ....
Board/Management Information
2025-04-28 English
Postal Ballot- Scrutinizer''s Report for Postal Ballot Notice dated March 27, 2025.
Declaration of Voting Results & Voting Rights Announcements
2025-04-28 English
Postal Ballot Result for Postal Ballot Notice dated March 27, 2025 seeking approval of the members for the resolution
Declaration of Voting Results & Voting Rights Announcements
2025-04-28 English
Rectification Of Typographical Error In Press Release - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2025-04-28 English
Press Release - Remedium Lifecare Limited -Ride the Pharma Wave with Our Rights Issue
Share Issue/Capital Change
2025-04-28 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2025-04-26 English
The Board of Directors of the Company at its meeting held today, i.e. April 24, 2025 have considered and approved inter alia the following: 1. The Letter of Offer, Abridged Letter of ....
Capital/Financing Update
2025-04-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement
2025-04-22 English
Remedium Lifecare Limited Outlines Strategic Objectives of Upcoming Rights Issue
Capital/Financing Update
2025-04-21 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 ,inter alia, to consider and approve 1. To Approve the Letter ....
Report Publication Announcement
2025-04-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement
2025-04-16 English
Press Release - Remedium Lifecare Announces ?49.19 Cr Rights Issue for Expansion
Share Issue/Capital Change
2025-04-08 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.
Regulatory Filings
2025-04-07 English
The Company has fixed Tuesday, 15th April, 2025 as Record Date for determining the equity shareholders entitled to receive rights entitlements in the Rights Issue.
Share Issue/Capital Change
2025-04-07 English
Outcome of Board Meeting held on April 07, 2025 for 1)Considering approving and fixing Tuesday, 15 April, 2025 as the ''Record Date'' for the purpose of determining the equity shareholders ....
Capital/Financing Update
2025-04-07 English
Postal Ballot- Scrutinizer''''s Report for Postal Ballot Notice dated April 02, 2025.
Declaration of Voting Results & Voting Rights Announcements
2025-04-02 English
Postal Ballot Result for Postal Ballot Notice dated March 01, 2025 seeking approval of the members for the resolution
Declaration of Voting Results & Voting Rights Announcements
2025-04-02 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2025 ,inter alia, to consider and approve 1. To consider and approve ....
Capital/Financing Update
2025-04-01 English
Newspaper Publication of Notice of Postal Ballot & Remote E-voting to members pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements ) Regulation 2015
Regulatory Filings
2025-03-29 English
Postal Ballot Notice Dated March 27,2025
Proxy Solicitation & Information Statement
2025-03-27 English
Intimation of closure of Trading window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2025-03-24 English
Newspaper Publication of Notice of Postal Ballot & Remote E-voting to members pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements ) Regulation 2015
Report Publication Announcement
2025-03-03 English
Postal Ballot Notice Dated March 01,2025
Proxy Solicitation & Information Statement
2025-03-01 English
Submission of Newspaper Clippings regarding Unaudited Financial Results for the quarter and Nine Months ended 31.12.2024
Earnings Release 9M 2025
2025-02-17 English
Intimation of receipt of Order under Regulation 30 of SEBI(LODR), Regulations, 2015.
Regulatory Filings
2025-02-15 English
Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024.
Interim / Quarterly Report 9M 2025
2025-02-14 English
Results For The Quarter and Nine Months Ended December 31, 2024.
Interim / Quarterly Report 9M 2025
2025-02-14 English
Outcome of Board Meeting held on Friday, February 14, 2025.
Interim / Quarterly Report 9M 2025
2025-02-14 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve 1) Consideration And Approval ....
Report Publication Announcement
2025-02-08 English
Outcome of Board Meeting for approval of Draft Letter of Offer in regards to the Rights Issue of Equity Shares.
Capital/Financing Update
2025-01-25 English
Postal Ballot- Scrutinizer''s Report for Postal Ballot Notice dated December 23, 2024.
Declaration of Voting Results & Voting Rights Announcements
2025-01-24 English
Postal Ballot Result for Postal Ballot Notice dated December 23, 2024 seeking approval of the members for the resolution
Declaration of Voting Results & Voting Rights Announcements
2025-01-24 English
In terms of Regulation 30 of SEBI (Listing Obligation Disclosure Requirement) Regulations, 2015 and in addition to disclosure regarding appointment of Director dated January 22nd 2025, ....
Board/Management Information
2025-01-22 English
Intimation for appointment of Ms. Shamim Adil Michal as an Additional (Non-Executive Independent) Director of the Company
Regulatory Filings
2025-01-22 English
Outcome of Board Meeting held on Wednesday, January 22, 2025 for 1) Right issue of shares 2) Increase in authorised share capital 3) Appointment of Additional Independent Director
Regulatory Filings
2025-01-22 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and approve raising funds by way of issue ....
Regulatory Filings
2025-01-17 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024.
Regulatory Filings
2025-01-10 English
We write to you in reference to recent media reports claiming that Remedium Lifecare Limited has received an order worth ?8,500 crore from Eli Lilly and Company. The reports further suggest ....
Regulatory Filings
2025-01-07 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform you about the following changes in composition ....
Board/Management Information
2025-01-04 English